Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Frank Bennett

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Nature|April 14, 2017
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2Daniel R Scoles, Pratap Meera, Matthew D Schneider, et al.
Neuron|May 24, 2016
Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse ModelKathleen M Schoch, Sarah L DeVos, Rebecca L Miller, et al.
The Journal of Clinical Investigation|March 22, 2016
Modulation of LMNA splicing as a strategy to treat prelamin A diseasesJohn M Lee, Chika Nobumori, Yiping Tu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Naked antisense oligonucleotides remain endolysosomally sequestered despite induced membrane damageEwa Sitarska, Anand Saminathan, Gustavo Scanavachi, et al.
Journal of the American Chemical Society|July 10, 2024
Tool to Resolve Distortions in Elemental and Isotopic ImagingChixiang Lu, Gu Chen, Wenxin Song, et al.
Nucleic Acid Therapeutics|June 13, 2017
The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG OligonucleotidesSuzanne Paz, Jill Hsiao, Patrick Cauntay, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 MiceDominic Jauvin, Jessina Chrétien, Sanjay K Pandey, et al.
Cancer Research|December 18, 2021
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma GrowthWai Kit Ma, Dillon M Voss, Juergen Scharner, et al.
Arthritis and Rheumatism|April 1, 2009
Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritisEvangelos Andreakos, Una Rauchhaus, Athanassios Stavropoulos, et al.
Cell Reports|April 22, 2014
Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophyAndrew P Lieberman, Zhigang Yu, Sue Murray, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Nature|April 14, 2017
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2Daniel R Scoles, Pratap Meera, Matthew D Schneider, et al.
Neuron|May 24, 2016
Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse ModelKathleen M Schoch, Sarah L DeVos, Rebecca L Miller, et al.
The Journal of Clinical Investigation|March 22, 2016
Modulation of LMNA splicing as a strategy to treat prelamin A diseasesJohn M Lee, Chika Nobumori, Yiping Tu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Naked antisense oligonucleotides remain endolysosomally sequestered despite induced membrane damageEwa Sitarska, Anand Saminathan, Gustavo Scanavachi, et al.
Journal of the American Chemical Society|July 10, 2024
Tool to Resolve Distortions in Elemental and Isotopic ImagingChixiang Lu, Gu Chen, Wenxin Song, et al.
Nucleic Acid Therapeutics|June 13, 2017
The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG OligonucleotidesSuzanne Paz, Jill Hsiao, Patrick Cauntay, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 MiceDominic Jauvin, Jessina Chrétien, Sanjay K Pandey, et al.
Cancer Research|December 18, 2021
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma GrowthWai Kit Ma, Dillon M Voss, Juergen Scharner, et al.
Arthritis and Rheumatism|April 1, 2009
Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritisEvangelos Andreakos, Una Rauchhaus, Athanassios Stavropoulos, et al.
Cell Reports|April 22, 2014
Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophyAndrew P Lieberman, Zhigang Yu, Sue Murray, et al.
Pageof 17